Getting to grips with complexity of disease will make genomics useful in arterial thrombosis.
Ariëns
R A S
RA
Leeds Institute for Genetics, Health and Therapeutics, Faculty of Medicine and Health, University of Leeds, Leeds, UK. r.a.s.ariens@leeds.ac.uk
D000925:Anticoagulants / Q000378:metabolism / Q000627:therapeutic use; D001157:Arterial Occlusive Diseases / Q000150:complications / Q000188:drug therapy / Q000235:genetics*; D020022:Genetic Predisposition to Disease; D023281:Genomics / Q000379:methods; D005838:Genotype; D006331:Heart Diseases / Q000235:genetics* / Q000517:prevention & control; D006801:Humans; D053858:Metabolic Networks and Pathways / Q000235:genetics; D010597:Pharmacogenetics / Q000379:methods; D010641:Phenotype; D011110:Polymorphism, Genetic; D012307:Risk Factors; D013927:Thrombosis / Q000150:complications / Q000188:drug therapy / Q000235:genetics*
D000925:Anticoagulants